For the first time ever, a human body was instructed to make lab-designed antibodies against SARS-CoV-2 - by itself - from synthetic DNA.
One shot.
No virus.
Protection lasting over a year.🧵
A new Nature Medicine study tested something called DNA-encoded monoclonal antibodies (DMAbs).
Instead of injecting ready made antibodies, scientists injected synthetic DNA that tells your cells how to make them.
Your muscle becomes a mini factory for antibodies.
The DNA carried blueprints for tixagevimab and cilgavimab - the antibodies used in Evusheld.
It was delivered intramuscularly, with short electric pulses (electroporation) that help DNA enter cells.
The results were remarkable.
Every participant developed measurable antibodies
Those antibodies neutralized multiple SARS-CoV-2 variants (Wuhan, Delta, Omicron BA.5)
Levels stayed detectable for 72 weeks (that’s 1.5 years!)
No serious adverse events
Crucially, no participant developed anti-drug antibodies (ADA) - immune reactions that often sabotage gene-based or protein therapies.
That means the DNA platform triggered expression, not inflammation.
This is a proof of concept that humans can safely express foreign genes from DNA
without integrating them into our genome and without immune rejection.
It’s controlled gene expression, virus-free and clean.
Why this matters
cheaper and more stable than traditional monoclonal antibodies
no cold chain needed
rapidly adaptable to new viral variants
potentially usable for autoimmune or cancer therapies
It’s a small phase 1 trial (44 healthy volunteers) and doesn’t prove real world protection yet.
But it’s the first clinical proof that DNA-coded antibodies can work in humans.
A short flight - but like the Wright brothers, it changes everything.
Immunologically, this is a new form of passive immunity
instead of teaching your body to make antibodies (as vaccines do),
you simply give it the genetic instructions.
And those instructions can last a year or more.
If this platform expands, it could redefine how we produce biologics.
No massive bioreactors. No frozen proteins.
Just a few milligrams of DNA and one injection.
Tebas et al., Nature Medicine (2025). Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults. nature.com/articles/s4159…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new preprint from Aarhus University shows something striking:
people with post-COVID, MCS, and functional disorders all share the same brain pattern -
split hemispheres, weakened bridges between left and right (!),
overloaded smell and sensory circuits🧵
The study scanned 57 women (post-COVID, MCS, FSD, controls) using diffusion MRI (DTI).
It didn’t measure brain activity, but rather its wiring - the white-matter highways that carry information between regions.
Result.
Interhemispheric connectivity - the bridge between left and right hemispheres - was reduced by 70% in all three patient groups.
That means information flow across the brain is slower, less coordinated, and less efficient.
A new study strengthens the view that SARS-CoV-2:
disrupts brain homeostasis,
alters ionic & neurotransmitter balance,
and triggers lasting epigenetic reprogramming.
Researchers exposed human primary astrocytes to Delta and Omicron.
The results are striking🧵
Astrocytes were infected with Delta and Omicron at a very low viral load (MOI 0.2).
After just 6 hours, RNA-seq revealed major transcriptional shifts
Omicron deregulated 346 genes (197 ↑, 149 ↓)
Delta deregulated 341 (215 ↑, 126 ↓)
About half of the changes overlapped.
Even minimal exposure triggered broad molecular changes within hours.
Viral sensing and immune response.
Astrocytes primarily activated TLR2, but not RIG-I or NLRP3 - meaning they sensed the virus without launching a full antiviral storm.
Only 16 genes involved in interferon and interleukin signaling were affected.
Even though Omicron often causes milder illness, it leaves a clear metabolic footprint disrupting liver, immune, and energy metabolism.
A new study shows that even 2-4 weeks after recovery, the body does not return to normal metabolic state🧵
Researchers analyzed blood serum from 300 Omicron patients, 200 recovered, and 380 healthy controls.
Using LC-MS metabolomics, they tracked hundreds of molecules revealing how the infection affects the liver, mitochondria, and immune system.
Over 100 metabolites were significantly altered during infection - that’s expected in any acute illness.
What’s not expected?
Most of these changes did not return to normal even after clinical recovery.
SARS-CoV-2 is not just a respiratory virus. It acts more like an epigenetic manipulator - a virus that rewires how our genes are read and expressed. A new study shows how the virus edits the body’s epigenetic code🧵
Instead of simply damaging cells, it reprograms the host’s immune system, changing the molecular instructions that guide how the body responds to infection.
This is why COVID-19 can leave such a deep biological footprint. The virus doesn’t have to remain active to keep affecting you - it can alter the settings of your immune and metabolic genes in ways that persist long after recovery.
Smell loss after COVID isn’t just a sensory symptom.
It’s a window into how the virus reshapes the emotional brain.
New imaging data reveal microstructural changes in the amygdala - linking smell, mood, and neuroplastic stress🧵
A new MRI study found structural changes in the amygdala - the brain’s emotional hub - in people with long term smell loss after COVID-19.
This goes far beyond the nose.
Loss of smell after COVID isn’t just damage to nasal cells.
In some people it persists for months or years - and the brain adapts.
Researchers used diffusion tensor MRI (DTI) to examine microstructural white-matter changes in key olfactory–emotional regions.
A possible new diagnostic approach to Long COVID.
Long COVID may involve microcirculatory blockages - tiny, persistent clots known as fibrinaloid microclots.
These abnormal fibrin structures resist breakdown and can obstruct blood flow in the smallest vessels.🧵
The result - local hypoxia, fatigue, muscle weakness, brain fog - classic long COVID symptoms.
Even a slight obstruction means tissues aren’t getting enough oxygen.
A new preprint study by Kell & Pretorius proposes a non-invasive diagnostic tool -
thermal imaging (IR thermography) - using skin temperature patterns to visualize microcirculatory dysfunction.